Döllken V.: Ueber die wirkung des aluminiums mit besonderer berücksichtigung der durch das aluminium verursachten lasionen im centralnervesystem. Arch fur Exper Path Pharmacol40:98-120, 1898
2.
Alfrey AC, LeGendre GR, Kaehny WD: The dialysis encephalopathy syndrome: Possible aluminum intoxication. N Engl J Med294:184-188, 1976
3.
Sideman S., Manor D.: The dialysis dementia syndrome and aluminum intoxication. Nephron31:1-10, 1982
4.
Ott SM, Maloney NA, Coburn JW, et al: The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. N Engl J Med307:709-713, 1982
5.
Alfrey A.: Origins and clinical effects of aluminum loading, in Aluminum Content of Parenteral Products. A public workshop held by theFood and Drug Administration, November 6, 1986, pp 16-28
Roodhooft AM , van de Vyver FL, D'Haese PC, et al: Aluminum accumulation in children on chronic dialysis: Predictive value of serum aluminum levels and desferrioxamine infusion test. Clin Nephrol28:125-129, 1987
8.
Clark BB: Drugs effective in ulcer therapy, in DiPalma JR (ed): Drill's Pharmacology in Medicine (ed 3). New York, McGraw-Hill , 1965, p 719
9.
Kaehny WD, Hegg AP, Alfrey AC: Gastrointestinal absorption of aluminum from aluminum-containing antacids . N Engl J Med296:1389-1390, 1977
10.
Yokel RA, McNamara PJ: Influence of renal impairment, chemical form and serum protein binding on intravenous and oral aluminum kinetics in the rabbit. Toxicol Appl Pharmacol95:32-43, 1988
11.
Alfrey AC, Hegg A., Craswell P.: Metabolism and toxicity of aluminum in renal failure. Am J Clin Nutr33:1509-1516, 1980
12.
Alfrey A.: Discussion, in Aluminum Content of Parenteral Products: A public workshop held by theFood and Drug Administration, November 6, 1986, p 73
13.
Skalsky HL, Carchman RA: Aluminum homeostasis in man. J Am Coll Toxicol2:405-423, 1983
14.
Williams JW , Vera SR, Peters TG, et al: Biliary excretion of aluminum in aluminum osteodystrophy with liver disease. Ann Int Med104:782-785, 1986
15.
Miller RG, Kopfler FC, Kelty KC, et al: The occurrence of aluminum in drinking water. J Am Water Works Assoc76:84-91, 1984
16.
Sedman AB, Klein GL, Merritt RJ, et al: Evidence of aluminum loading in infants receiving intravenous therapy. N Engl J Med312:1337-1343, 1985
17.
Hewitt CD, O'hara M., Day JP, et al: Exposure of infants to aluminium from milk formulae and intravenous fluids, in Bratter P, Schramel P (eds): Trace Element Analytical Chemistry in Medicine and Biology, vol4. New York, de Gruyter, 1987, pp 481-488
18.
Vyth A., Stolk Lml, Abbad Fcb: Aluminum contamination of dialysis and intravenous fluids after asbestos-free depth filtration. Am J Hosp Pharm43:2390, 1986
19.
Boylan JC, Rabinow B.: Discussion, in Aluminum Content of Parenteral Products. A public workshop held by theFood and Drug Administration, November 6, 1986, pp 52-53
20.
Klein GL, Alfrey AC, Miller NL, et al: Aluminum loading during total parenteral nutrition. Am J Clin Nutr35:1425-1429, 1982
21.
Goldstein M.: Origins and clinical effects of aluminum loading, in Aluminum Content of Parenteral Products. A public workshop held by theFood and Drug Administration, November 6, 1986, pp 35-40
22.
Santora A.: Overview, in Aluminum Content of Parenteral Products. A public workshop held by theFood and Drug Administration, November 6, 1986, pp 6-13
23.
Milliner DS , Feldman F., Shinaberger JH, et al: Aluminum contamination of albumin-replacement solutions. N Engl J Med312:1390, 1985
24.
Fell GS, Maharaj D.: Trace metal contamination of albumin solutions used for plasma exchange. Lancet2:467-468, 1986
25.
Cuthbertson B., McBay WE, Welch AG, et al: Aluminium and human albumin solutions . Br Med J295:1062, 1987
26.
Joelt SV, Malling H-J., Svendsen UG, et al: Serum aluminium in hyposensitized allergics. Allergy40:487-490, 1985
27.
Freundlich M., Abitbol C., Zilleruelo G., et al: Infant formula as a cause of aluminium toxicity in neonatal uraemia. Lancet2:527-529, 1985
28.
Weintraub R. , Hams G., Meerkin M., et al: High aluminium content of infant milk formulas. Arch Dis Child61:914-916, 1986
29.
Beal GD, Unangst RB, Wigman HB, et al: Aluminum content of foodstuffs cooked in glass and in aluminum . Ind Eng Chem24:405-407, 1932
30.
Sorenson Jrj , Campbell IR, Tepper LB, et al: Aluminum in the environment and human health. Environ Health Perspect8:3-95, 1974
31.
Greger JL: Aluminum content of the American diet. Food Tech39:73-80, 1985
32.
Sullivan DM, Kehoe DF, Smith RL: Measurement of trace levels of total aluminum in foods by atomic absorption spectrophotometry. J Assoc Off Anal Chem70:118-120, 1987
33.
Pennington Jat : Aluminium content of foods and diets. Food Addit Contam5:161-232, 1987
34.
Lione A.: The prophylactic reduction of aluminium intake. Food Chem Toxicol21:103-109, 1983
35.
Poe CF, Leberman JM: The effect of acid foods on aluminum cooking utensils. Food Tech3:71-74, 1949
36.
The Lancet Laboratory: Some kitchen experiments with aluminium. Lancet1:54-55, 1913
37.
Am Med Assoc Council on Foods and Nutrition : The use of aluminum cooking utensils in the preparation of foods. JAMA146:477, 19511
38.
Lione A.: The reduction of aluminum intake in patients with Alzheimer's disease. J Environ Path Tox Oncol6:21-32, 1985
39.
Lione A., Allen PV, Smith JC: Aluminium coffee percolators as a source of dietary aluminium. Food Chem Toxicol22:265-268, 1984
O'Donovan R. , Baldwin D., Hammer M., et al: Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia. Lancet1:880-882, 1986
42.
Ittel TH, Buddington B., Miller NL, et al: Enhanced gastrointestinal absorption of aluminum in uremic rats . Kidney Int32:821-826, 1987
43.
Spofforth J. : Case of aluminium poisoning. Lancet1:1301, 1921
44.
McLaughlin Aig, Kazantizis G., King E., et al: Pulmonary fibrosis and encephalopathy associated with the inhalation of aluminium dust. Br J Ind Med19:253-263, 1962
45.
Sjogren B., Lundberg I., Lidums V.: Aluminium in the blood and urine of industrially exposed workers. Br J Ind Med40:301-304, 1983
46.
Mussi I., Calzaferri G., Buratti M., et al: Behaviour of plasma and urinary aluminium levels in occupationally exposed subjects. Int Arch Occup Environ Health54:155-161, 1984
Klatzo I., Wisniewski H., Streicher E.: Experimental production of neurofibrillary degeneration. I. Light microscopic observations. J Neuropathol Exp Neurol24:187-199, 1965
49.
Terry RD, Pena C.: Experimental production of neurofibrillary degeneration. 2. Electron microscopy, phosphatase histochemistry and electron probe analysis. J Neuropathol Exp Neurol24:200-210, 1965
50.
Perl DP, Brody AR: Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science208:297-299, 1980
51.
Spencer PS, Nunn PB, Hugon J., et al: Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science237:517-522, 1987
52.
Perl DP, Gajdusek DC, Garruto RM, et al: Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Science217:1053-1055, 1982
53.
Bertholf RL : Aluminum and Alzheimer's disease: Perspectives for a cytoskeletal mechanism. CRC Crit Rev Clin Lab Sci25:195-210, 1987
Candy JM, Klinowski J., Perry RH, et al: Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet1:354-357, 1986
56.
Crapper DR, Krishnan SS, Dalton AJ: Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science180:511-513, 1973
57.
Trapp GA, Miner GD, Zimmerman RL, et al: Aluminum levels in brain in Alzheimer's disease. Biol Psych13:709-718, 1978
58.
McDermott JR , Smith AI, Iqbal K., et al: Aluminium and Alzheimer's disease . Lancet2:710-711, 1977
59.
Markesbery WR, Ehmann WD, Hossain Tim, et al: Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging. Ann Neurol10:511-516, 1981
60.
Ward NI, Masson JA: Neutron activation analysis techniques for identifying elemental status in Alzheimer's disease. J Radioanal Nuclear Chem113:515-526, 1987
61.
Krishnan SS , Harrison JE, Crapper McLachlan DR: Origin and resolution of the aluminum controversy concerning Alzheimer's neurofibrillary degeneration . Biol Tr El Res13:35-42, 1987
62.
Kellett JM, Taylor A., Oram JJ: Aluminosilicates and Alzheimer's disease. Lancet1:682, 1986
63.
McLachlan DR, Dalton AJ, Galin H.: Effect of desferrioxamine on clinical course of Alzheimer's disease. Presentation at Canadian and American Gerontological Association Meetings, Toronto, November, 1981, and personal communication from DR Crapper McLachlan
64.
Shore D., Sprague SM, Mayor GH, et al: Aluminum-fluoride complexes: Preclinical studies. J Environ Path Tox Oncol6:9-13, 1985, and personal communication from D Shore
65.
Mozar HN, Bal DG, Howard JT: Perspectives on the etiology of Alzheimer's disease. JAMA257:1503-1507, 1987
